1. Cefotaxime-related DRESS syndrome

   News item 17 February 2024 Pages: 1 - 1

2. FDA finalises guidance on its postmarketing safety surveillance

   News item 17 February 2024 Pages: 2 - 2

3. Liposomal amphotericin B-related hyperkalaemia

   News item 17 February 2024 Pages: 3 - 3

4. New valproate safety measures in the UK

   News item 17 February 2024 Pages: 4 - 4

5. PRAC meeting Feb 2024: reminder of Paxlovid drug interactions

   News item 17 February 2024 Pages: 5 - 5

6. Serious pseudoephedrine-related AEs

   News item 17 February 2024 Pages: 6 - 6

7. Tolnaftate foot spay recalled due to elevated levels of benzene

   News item 17 February 2024 Pages: 7 - 7

8. Traditional Chinese medicine Gu Jie Ling contains dexamethasone

   News item 17 February 2024 Pages: 8 - 8

9. ADRs reduce adherence to antidepressant treatment

   Unknown 17 February 2024 Pages: 9 - 9

10. Drug-induced interstitial lung disease

    Clinical study 17 February 2024 Pages: 10 - 10

11. Drug-induced PML greatest with natalizumab for MS

    Clinical study 17 February 2024 Pages: 11 - 11

12. Lipid-lowering therapy-related risk of haemorrhagic stroke

    Clinical study 17 February 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 17 February 2024 Pages: 13 - 13

14. Ad26.COV2-S

    Case report 17 February 2024 Pages: 14 - 14

15. Afatinib

    Case report 17 February 2024 Pages: 15 - 15

16. Alectinib

    Case report 17 February 2024 Pages: 16 - 16

17. Alendronic-acid

    Case report 17 February 2024 Pages: 17 - 17

18. Alendronic-acid/Meloxicam/Nitrofurantoin

    Case report 17 February 2024 Pages: 18 - 18

19. Alendronic-acid/minodronic-acid/risedronic-acid

    Case report 17 February 2024 Pages: 19 - 19

20. Alpelisib

    Case report 17 February 2024 Pages: 20 - 20

21. Amiodarone

    Case report 17 February 2024 Pages: 21 - 21

22. Amlodipine

    Case report 17 February 2024 Pages: 22 - 22

23. Antibacterials

    Case report 17 February 2024 Pages: 23 - 24

24. Antiepileptic-drugs/immune-globulin/methylprednisolone

    Case report 17 February 2024 Pages: 24 - 24

25. Antifungals/Azathioprine

    Case report 17 February 2024 Pages: 25 - 25

26. Antihistamines/ciclosporin/corticosteroids

    Case report 17 February 2024 Pages: 26 - 26

27. Antihyperglycaemics

    Case report 17 February 2024 Pages: 27 - 27

28. Antineoplastics

    Case report 17 February 2024 Pages: 28 - 28

29. Antineoplastics/glucocorticoids

    Case report 17 February 2024 Pages: 29 - 29

30. Antituberculars and methylprednisolone

    Case report 17 February 2024 Pages: 30 - 30

31. Atezolizumab

    Case report 17 February 2024 Pages: 31 - 31

32. Atezolizumab

    Case report 17 February 2024 Pages: 32 - 32

33. Atezolizumab/bevacizumab

    Case report 17 February 2024 Pages: 33 - 33

34. Atezolizumab/sotorasib

    Case report 17 February 2024 Pages: 34 - 34

35. Atropine/pralidoxime-chloride

    Case report 17 February 2024 Pages: 35 - 35

36. Avapritinib/midostaurin

    Case report 17 February 2024 Pages: 36 - 36

37. Azathioprine

    Case report 17 February 2024 Pages: 37 - 37

38. AZD-1222/Elasomeran/Tozinameran

    Case report 17 February 2024 Pages: 38 - 38

39. AZD-1222/prednisone/tozinameran

    Case report 17 February 2024 Pages: 39 - 39

40. BCG-vaccine

    Case report 17 February 2024 Pages: 40 - 40

41. Betamethasone/dexchlorpheniramine

    Case report 17 February 2024 Pages: 41 - 41

42. Bevacizumab/cidofovir

    Case report 17 February 2024 Pages: 42 - 42

43. Bortezomib/dexamethasone/selinexor

    Case report 17 February 2024 Pages: 43 - 43

44. Bortezomib/lenalidomide

    Case report 17 February 2024 Pages: 44 - 44

45. Bortezomib/zoledronic-acid

    Case report 17 February 2024 Pages: 45 - 45

46. Brexucabtagene-autoleucel/ibrutinib/lenalidomide

    Case report 17 February 2024 Pages: 46 - 46

47. Buprenorphine/buprenorphine/naloxone

    Case report 17 February 2024 Pages: 47 - 47

48. Camrelizumab/tislelizumab

    Case report 17 February 2024 Pages: 48 - 48

49. Carboplatin/Etoposide

    Case report 17 February 2024 Pages: 49 - 49

50. Carboplatin/nivolumab/paclitaxel

    Case report 17 February 2024 Pages: 50 - 50